Join us in transforming Vision through Artificial Intelligence
The A-eye Summit in Ophthalmology is a first of its kind opportunity to unite academia, clinicians, and industry as we harness the power of artificial intelligence across anterior and posterior eye diseases.
Our mission is to redefine how we understand and measure disease progression – from identifying predictive biomarkers to characterizing patient groups with unprecedented precision. By transforming data into insight, we aim to accelerate discovery, optimize clinical studies, and empower personalized patient care.
Following the success of the 1st Annual Summit on AI in Geographic Atrophy, the organizers have identified a broader unmet need on the topic of the application of AI in ophthalmology.
To address this, the Aeye Summit will return in 2026 with sessions at ARVO in Denver and AAO in New Orleans.
Our objective :
To create a collaborative environment that accelerates the use of AI in ophthalmology in:
• Retina • Glaucoma • Cataract • Cornea • Myopia
ORGANIZERS
Sharon Bakalash MD, PhD, CBA – Founder
Dr. Sharon Bakalash is an experienced ophthalmic surgeon with over two decades of proven leadership in clinical and scientific ophthalmic medicine in the Biotech and MedTech industries. As a consultant, she assists in shaping development strategies and facilitating pipeline enrichment through both internal and external innovation.
As the head of ophthalmic medical affairs at Astellas she is at the forefront of the use of Ai in ophthalmology.in an effort to initiate collaborations between industry, research and clinicians to advance the use of Ai in Ophthalmology, she founded the first AI summit in Geographic Atrophy in 2024.
Prof. Anat Loewenstein – Committee Member
A global leader in retinal innovation and artificial intelligence in ophthalmology. As Chair of the Department of Ophthalmology at Tel Aviv Sourasky (Ichilov) Medical Center and Vice Dean of the Faculty of Medicine at Tel Aviv University, she has driven the integration of AI-based tools into retinal imaging, diagnosis, and clinical decision-making. Her research has advanced automated detection and monitoring of age-related macular degeneration and diabetic retinopathy, shaping the future of data-driven eye care. Professor Loewenstein continues to champion multidisciplinary collaboration between clinicians, engineers, and industry to accelerate the responsible adoption of AI in ophthalmology worldwide.
Dr. Omer Trivitzki – Committee Member
Dr. Omer Trivizki, MD, Chief Medical Officer at Ichilov-Tech and Deputy Chair of Ophthalmology at Tel Aviv Medical Center, is a retina specialist and innovator in applying artificial intelligence to ophthalmic care. His work focuses on integrating AI to enhance diagnostics, streamline clinical workflows, and improve patient outcomes. A published expert on clinician–AI collaboration, Dr. Trivizki bridges clinical leadership with technological innovation, advancing the responsible and practical adoption of AI in eye care.
Dr. I. Paul Singh – Committee Member
Dr. I. Paul Singh is a pioneer in translating cutting-edge technology into clinical practice. As President of The Eye Centers of Racine & Kenosha and director of a full-time research facility, Dr. Singh bridges innovation and patient care through extensive research across glaucoma, cataract, retina, and ocular surface disease. A fellowship-trained glaucoma specialist from Duke University, he has championed the adoption of minimally invasive surgical techniques and AI-driven diagnostic tools in community practice settings. Recognized by Newsweek as America's Best Eye Doctor in 2021, Dr. Singh continues to advance the responsible integration of AI in ophthalmology through strategic collaboration between research, technology, and clinical excellence.
Prof. Damien Gatinel, MD, PhD – Committee Member
Prof. Damien Gatinel is a world-renowned innovator in anterior segment surgery and artificial intelligence applications in ophthalmology. As Head of the Anterior and Refractive Surgery Department at the Rothschild Foundation in Paris, Professor Gatinel has pioneered the integration of AI and mathematical modelling into corneal imaging, IOL power calculation, and keratoconus detection. With a PhD in applied mathematics, he developed the PEARL-DGS formula and holds the patent for the first diffractive trifocal IOL design. Recipient of 22 international awards including the AAO Senior Achievement Award and 17 ASCRS Best Paper honors, Professor Gatinel advances AI-driven precision in ocular diagnostics through his leadership on the ESCRS Digital Health Committee and ISRS Executive Committee.